"This study was attractive because the drug was oral, and patients don't have to come into the center. They can take it from home," Dr. Wendland says. Read more.
The first two chronic lymphocytic leukemia (CLL) patients ever in the world to receive a new, potentially life-saving drug for B-cell cancers were part of a clinical trial run by Dr. Jeff Sharman at WVCI. Read more.
A sensible approach to eating for better health, presented by Dietician Shelly Kokkeler, MS, RD, CSO, LD.
Monday, May 20
5:30 - 6:30 pm
Willamette Valley Cancer Institute Community Room
520 Country Club Road
Call 541-681-4949 to register Read more.
Willamette Valley Cancer Institute and Research Center hosted a Prostate Cancer Symposium attended by Eugene/Springfield-area primary care physicians and clinicians. The symposium was an unprecedented step in creating better awareness and collaborations among local providers who diagnose and treat prostate patients. Read more.
Dr. Sharman is highlighted in this U.S. Oncology Network video focusing on his blood cancer research and his studies in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). Read more.